Thursday, 30 May 2013

Great News For Gilead Sciences And HCV Patients

Great News For Gilead Sciences And HCV PatientsSeeking AlphaGilead submitted a New Drug Application [NDA] with the same Phase 3 trial data to the FDA in April 2013. The FDA has since issued a Form 483 letter questioning the company's test procedures, stability testing and laboratory controls regarding several ...http://seekingalpha.com/article/1465861-great-news-for-gilead-sciences-and-hcv-patients?source=google_news

No comments:

Post a Comment